SCHEMBL712708

SCHEMBL712708

C[Si](C)(C)C#CCCCCC(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.41
PTPN7 P35236 5/20 0.37
HMGCR P04035 3/20 0.37
RECQL P46063 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
MCL1 Q07820 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9262800 0.82 PAOX (0.40) ALDH1A1PTPN7HMGCRRECQLTDP1
SCHEMBL710828 0.82 PTPN7 (0.57) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL31682065 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL31682050 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL22029362 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL4060730 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL9551566 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL4063611 0.80 PTPN7 (0.60) ALDH1A1TSHRPTPN7HMGCRRECQL
SCHEMBL16420274 0.78 RAB9A (0.33)
SCHEMBL14007874 0.77 ALDH1A1 (0.48) ALDH1A1TSHRTP53PTPN7HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124778-B2 Tricyclic inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-02-28 US disclosed
US-20100216750-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2010-08-26 US disclosed
EP-2161997-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE Boger, Dale L. (US) 2010-03-17 EP disclosed
WO-2008150492-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216750-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE FADS1, FAAH, SCD ALDH1A1 753/4885TSHR 1887/4885TP53 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.